Glass particles found in generic atorvastatin

BMJ 2012; 345 doi: (Published 03 December 2012) Cite this as: BMJ 2012;345:e8236
  1. Edward Davies
  1. 1New York

Ranbaxy Pharmaceuticals has stopped production and issued a recall of its generic version of the cholesterol lowering drug atorvastatin.

The recall applies to certain lots of the company’s 10 mg, 20 mg, and 40 mg tablets. The lots of atorvastatin, packaged in bottles of 90 and 500 tablets, are being …

View Full Text

Log in

Log in through your institution


* For online subscription